D349-4343 Screening compound: 1-(diphenylmethyl)-4-[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

D349-4343 Screening compound: 1-(diphenylmethyl)-4-[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine
D349-4343 Screening compound: 1-(diphenylmethyl)-4-[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound D349-4343
1-(diphenylmethyl)-4-[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D349-4343

Molecular Formula

C25H25N5O (C25 H25 N5 O)

Compound Name

1-(diphenylmethyl)-4-[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]piperazine

IUPAC name

1-(diphenylmethyl)-4-[3-(3-methyl-124-oxadiazol-5-yl)pyridin-2-yl]piperazine

SMILES

Cc1noc(-c2c(N(CC3)CCN3C(c3ccccc3)c3ccccc3)nccc2)n1

InChI

InChI=1S/C25H25N5O/c1-19-27-25(31-28-19)22-13-8-14-26-24(22)30-17-15-29(16-18-30)23(20-9-4-2-5-10-20)21-11-6-3-7-12-21/h2-14,23H,15-18H2,1H3

InChI Key

WMWSFCQWVNSFSV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14821916

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.628

Distribution Coefficient, logD

4.040

Water Solubility, LogSw

-4.41

Polar Surface Area

46.523

Acid Dissociation Constant (pKa)

23.40

Base Dissociation Constant (pKb)

7.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

D349-4343 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Nervous system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D349-4343 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D349-4343?
Check Price and Availability of D349-4343, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D349-4343 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D349-4343
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D349-4343
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D349-4343 available by request